Implantable drug delivery systems offer controlled, long-acting, and site-specific release of active pharmaceutical ingredients, providing therapeutic benefits across oncology, pain management, contraception, ophthalmology, and more. Due to technical complexity and strict regulatory requirements, successful development depends on working with experienced implants CDMO companies.
With expertise in formulation, device integration, and aseptic production, specialized implants contract manufacturing partners help pharmaceutical and medtech innovators bring safe, effective, and scalable implantable products to market.
How to Choose Implants CDMO Companies
When selecting among implants CDMO companies, key evaluation points include:
- Material expertise: Biodegradable polymers (e.g., PLGA, PLA), silicones, and titanium-based systems
- Manufacturing technologies: Extrusion, compression molding, hot melt, injection molding, and 3D printing
- Combination product capabilities: Integration of drug and device elements
- Sterilization experience: E-beam, gamma, or aseptic processing
- Regulatory compliance: Familiarity with FDA, EMA, MDR, and ISO 13485 standards
- Support for complex filing types: IND/NDA, IDE/PMA, 505(b)(2), or medical device pathways
A qualified CDMO ensures implant safety, reliability, and long-term performance.
Key Services Offered by Implants Contract Manufacturers
Full-service implants contract manufacturing providers typically offer:
- Formulation development: For long-acting and biodegradable implants
- Device prototyping and scale-up: Using custom tooling and 3D printing
- Aseptic and terminal sterilization: Compatible with sensitive APIs
- Combination product development: Drug + device under QMS
- In vitro release testing and stability studies
- Container closure and packaging design: For implant kits or single-use systems
- Regulatory support: For drug-device submissions
- GMP manufacturing: For clinical and commercial scale
These services support innovation while ensuring the safety and consistency of complex implantable systems.
Advantages of Partnering with Implants CDMO Companies
Working with top-tier implants CDMO companies offers key advantages:
- Controlled, site-specific drug delivery: For improved therapeutic outcomes
- Extended-release profiles: Reduce dosing frequency and improve adherence
- Integrated device and drug development: To accelerate timelines
- Regulatory clarity: With combination product experience
- Flexible manufacturing options: From early development through market launch
The right CDMO minimizes technical and regulatory risks across the product lifecycle.
Implants CDMO Companies
Some of the most trusted implants CDMO companies include:
- Sichuan Huiyu Pharmaceuticals: Specializes in CMO/CDMO services for APIs and complex injectables, including implants, liposomes, high-potency, oncology, cytotoxic, and corticosteroid drugs. [See CDMO profile]
- Ascil Biopharm: A GMP facility fully equipped for R&D and pharmaceutical development. [See CDMO profile]
- i+Med: Developer and manufacturer of new drug products with controlled-release technologies. [See CDMO profile]
- Green Phoenix Labs GmbH: Cell therapy company offering excess cleanroom capacity to support advanced pharmaceutical and biotechnological manufacturing activities. [See CDMO profile]
Related Information
Let MAI CDMO Help You Find the Right Implants CDMO Partner
At MAI CDMO, we connect pharmaceutical and medtech companies with the most experienced implants CDMO companies worldwide. Whether you’re creating a subcutaneous implant, an ocular insert, or a long-acting drug-eluting system, our network of implants contract manufacturing partners is equipped to bring your innovation to life — safely, efficiently, and compliantly.
Need help bringing your implantable product to market? Contact us today to find the ideal CDMO.
